Skip to content

miR-155 harnesses Phf19 to potentiate cancer immunotherapy through epigenetic reprogramming of T cell fate

  • Authors

    • Prof. Luca Gattinoni

    • Prof. Luca Gattinoni

  • Date Published

    August 17, 2019

Ji Y, Fioravanti J, Zhu W, Wang H, Wu T, Hu J, Lacey NE, Gautam S, Le Gall J, Yang X, Hocker JD, Escobar TM, He S, Dell’Orso S, Hawk NV, Kapoor V, Telford WG, Di Croce L, Muljo SA, Zhang Y, Sartorelli V, Gattinoni L. miR-155 harnesses Phf19 to potentiate cancer immunotherapy through epigenetic reprogramming of T cell fate. Nat Commun. 2019 May 14;10(1):2157. doi: 10.1038/s41467-019-09882-8. PMID: 31089138